Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis

All currently licensed medications for multiple sclerosis (MS) target the immune system. Albeit promising preclinical results demonstrated disease amelioration and remyelination enhancement via modulating oligodendrocyte lineage cells, most drug candidates showed only modest or no effects in human c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xinda, Jacob, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093908/
https://www.ncbi.nlm.nih.gov/pubmed/37047344
http://dx.doi.org/10.3390/ijms24076373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093908/
https://www.ncbi.nlm.nih.gov/pubmed/37047344
http://dx.doi.org/10.3390/ijms24076373

Ejemplares similares